Tongrentang's (600085.SH) subsidiary obtains Hong Kong proprietary Chinese medicine registration certificate for Dingzhi Pills.

Zhito Finance APP News, Tongrentang (600085.SH) announced that the company has learned that its controlled subsidiary Beijing Tongrentang Chinese Medicine Co., Ltd. has received a "Traditional Chinese Medicine Registration Certificate" issued by the Chinese Medicine Council of the Hong Kong Special Administrative Region of the People's Republic of China (referred to as Hong Kong), permitting the sale of "Dingzhi Wan [Tongrentang]" in Hong Kong. The drug's indications are to replenish qi and nourish the heart, calm the mind and stabilize the will.